AngioDynamics Inc (ANGO)
6.24
+0.07
(+1.13%)
USD |
NASDAQ |
May 28, 16:00
6.255
+0.02
(+0.24%)
After-Hours: 20:00
AngioDynamics Accounts Receivable (Quarterly): 49.48M for Feb. 29, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 49.48M |
November 30, 2023 | 51.60M |
August 31, 2023 | 49.76M |
May 31, 2023 | 52.83M |
February 28, 2023 | 50.89M |
November 30, 2022 | 52.85M |
August 31, 2022 | 53.59M |
May 31, 2022 | 52.30M |
February 28, 2022 | 41.81M |
November 30, 2021 | 38.20M |
August 31, 2021 | 35.42M |
May 31, 2021 | 35.40M |
February 28, 2021 | 33.17M |
November 30, 2020 | 33.60M |
August 31, 2020 | 33.59M |
May 31, 2020 | 31.26M |
February 29, 2020 | 35.62M |
November 30, 2019 | 33.99M |
August 31, 2019 | 32.54M |
May 31, 2019 | 43.58M |
February 28, 2019 | 44.21M |
November 30, 2018 | 43.37M |
August 31, 2018 | 40.16M |
May 31, 2018 | 39.40M |
February 28, 2018 | 41.83M |
Date | Value |
---|---|
November 30, 2017 | 42.07M |
August 31, 2017 | 41.28M |
May 31, 2017 | 44.52M |
February 28, 2017 | 46.30M |
November 30, 2016 | 50.17M |
August 31, 2016 | 50.12M |
May 31, 2016 | 52.87M |
February 29, 2016 | 54.45M |
November 30, 2015 | 53.12M |
August 31, 2015 | 52.42M |
May 31, 2015 | 58.43M |
February 28, 2015 | 57.77M |
November 30, 2014 | 58.56M |
August 31, 2014 | 56.03M |
May 31, 2014 | 61.97M |
February 28, 2014 | 57.73M |
November 30, 2013 | 48.40M |
August 31, 2013 | 46.56M |
May 31, 2013 | 47.68M |
February 28, 2013 | 45.11M |
November 30, 2012 | 47.08M |
August 31, 2012 | 45.43M |
May 31, 2012 | 48.59M |
February 29, 2012 | 26.72M |
November 30, 2011 | 31.45M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
31.26M
Minimum
May 2020
53.59M
Maximum
Aug 2022
42.07M
Average
40.01M
Median
Accounts Receivable (Quarterly) Benchmarks
Becton Dickinson & Co | 2.559B |
Outset Medical Inc | 36.48M |
Boston Scientific Corp | 2.304B |
Perspective Therapeutics Inc | 0.999M |
Xtant Medical Holdings Inc | 21.48M |